Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 7;22(7):1044-1045.
doi: 10.1093/neuonc/noaa065.

Recurrent IDH mutations in high-grade meningioma

Corey M Gill  1 , Joshua Loewenstern  1 , John W Rutland  1 , Hanane Arib  2 , Nancy Francoeur  2 , Ying-Chih Wang  2 , Nataly Fishman  2 , Margaret Pain  1 , Melissa Umphlett  3 , Yayoi Kinoshita  3 , Russell B McBride  3   4 , Joshua Bederson  1 , Michael Donovan  3 , Melissa Smith  2 , Robert Sebra  5 , Raj K Shrivastava  1 , Mary Fowkes  3
Affiliations

Recurrent IDH mutations in high-grade meningioma

Corey M Gill et al. Neuro Oncol. .
No abstract available

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
(A) Sagittal CT demonstrating right frontal mass measuring 4.1 cm × 3.6 cm × 4.1 cm. (B) WHO grade II atypical meningioma on hematoxylin and eosin (10x) with focal brain invasion (shown at the bottom right).
See this image and copyright information in PMC

References

    1. Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro Oncol. 2018;20(suppl_4):iv1–iv86. - PMC - PubMed
    1. Louis DN, Ohgaki H, Wiestler OD, et al. . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109. - PMC - PubMed
    1. Louis DN, Perry A, Reifenberger G, et al. . The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathologica. 2016;131(6):803–820. - PubMed
    1. Pain M, Wang H, Lee E, et al. . Treatment-associated TP53 DNA-binding domain missense mutations in the pathogenesis of secondary gliosarcoma. Oncotarget. 2018;9(2):2603–2621. - PMC - PubMed

Substances